Apotea (APOTEA) — Capital Reinvestment Ratio
Apotea (APOTEA) has a Capital Reinvestment Ratio of 0.02x as of March 2026, meaning it reinvests 0% of its operating cash flow (Skr112.50 Million) in capital expenditures (Skr1.70 Million). See Apotea balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Apotea Capital Reinvestment Ratio (2022–2025)
This chart tracks Apotea's Capital Reinvestment Ratio across 4 annual periods. Check Apotea total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Apotea (2022–2025)
Year-by-year Capital Reinvestment Ratio for Apotea from 2022 to 2025. For live market cap and broader valuation context, see Apotea (APOTEA) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.65x | Skr333.30 Million | Skr215.60 Million | ▼ -18.6% |
| 2024 | 0.79x | Skr206.20 Million | Skr163.80 Million | ▲ +41.6% |
| 2023 | 0.56x | Skr215.80 Million | Skr121.10 Million | ▼ -87.6% |
| 2022 | 4.51x | Skr31.50 Million | Skr142.10 Million | — |